Published in Mem Inst Oswaldo Cruz on December 11, 2015
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Chagas disease. Lancet (2010) 10.25
Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther (1977) 8.46
The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) (1985) 7.53
Major depressive disorder. N Engl J Med (2008) 6.61
The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) (1987) 5.35
A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz (2009) 4.27
Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis (2001) 4.13
Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav (1991) 2.04
Tissue tropism of different Trypanosoma cruzi strains. J Parasitol (1978) 1.83
SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. Neurosci Lett (2001) 1.70
Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect (2000) 1.63
Depression and cardiovascular disease: a call for recognition. Circulation (2005) 1.53
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med (2012) 1.37
Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) (2002) 1.30
Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying. Life Sci (2005) 1.15
Generalized anxiety disorder: A comorbid disease. Eur Neuropsychopharmacol (2006) 1.12
CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS Pathog (2012) 1.08
Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLoS One (2011) 1.03
Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. J Clin Psychiatry (2001) 1.01
Strain differences in fear-motivated behavior of rats. Pharmacol Biochem Behav (1996) 0.98
Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens. Clin Immunol (1999) 0.92
Central nervous system involvement in Chagas disease: a hundred-year-old history. Trans R Soc Trop Med Hyg (2009) 0.91
Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease. Mediators Inflamm (2014) 0.89
The history, epidemiology, and differential diagnosis of social anxiety disorder. J Clin Psychiatry (1999) 0.88
Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease. Mem Inst Oswaldo Cruz (2014) 0.87
Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment. PLoS One (2011) 0.87
Suicide risk and alcohol and drug abuse in outpatients with HIV infection and Chagas disease. Rev Bras Psiquiatr (2014) 0.86
Acute experimental Trypanosoma cruzi infection: establishing a murine model that utilises non-invasive measurements of disease parameters. Mem Inst Oswaldo Cruz (2012) 0.85
[Signs, meanings, and actions associated with Chagas disease]. Cad Saude Publica (2002) 0.83
Predictive validity of a non-induced mouse model of compulsive-like behavior. Behav Brain Res (2011) 0.82
Essential role of VLA-4/VCAM-1 pathway in the establishment of CD8+ T-cell-mediated Trypanosoma cruzi-elicited meningoencephalitis. J Neuroimmunol (2003) 0.82
Preferential brain homing following intranasal administration of Trypanosoma cruzi. Infect Immun (2009) 0.81
A new method for quantitative grip strength evaluation. Eur J Pharmacol (1969) 0.81
Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions. Brain Behav Immun (2012) 0.81
Paradoxical increase of exploratory behavior in the elevated plus-maze by rats exposed to two kinds of aversive stimuli. Braz J Med Biol Res (1997) 0.80
Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat. Behav Brain Res (2011) 0.80
[Encephalopathic forms of chronic Chagas disease seen in Argentina]. Mem Inst Oswaldo Cruz (1983) 0.79
Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response. PLoS Negl Trop Dis (2015) 0.79
Quality of life and depressive symptoms in Chagas disease patients. Qual Life Res (2010) 0.78
[Anxiety-depressive disorders and stroke: possible etiopathogenetic correlations]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.77
Chagas disease as a mechanistic model for testing a novel hypothesis. Rev Soc Bras Med Trop (2008) 0.77
Interferon-gamma promotes infection of astrocytes by Trypanosoma cruzi. PLoS One (2015) 0.77
Apomorphine effect on single and paired rat open-field behavior. Physiol Behav (1991) 0.76